[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002277:Carcinoma / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D010478:Chemotherapy, Cancer, Regional Perfusion; D003131:Combined Modality Therapy; D005260:Female; D019788:Fluorodeoxyglucose F18; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D005833:Genital Neoplasms, Female / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D006801:Humans; D006979:Hyperthermia, Induced; D010535:Laparoscopy; D018579:Patient Selection; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary / Q000601:surgery*; D010537:Peritoneum / Q000601:surgery*; D049268:Positron-Emission Tomography; D011379:Prognosis; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D019788:Fluorodeoxyglucose F18
Selektion zur Peritonektomie mit hyperthermer intraoperativer Chemotherapie (HIPEC) bei Peritonealkarzinose.